Activation of three types of voltage‐independent Ca2+ channel in A7r5 cells by endothelin‐1 as revealed by a novel Ca2+ channel blocker LOE 908
We have shown that in addition to voltage‐operated Ca2+ channel (VOC), endothelin‐1 (ET‐1) activates two types of Ca2+‐permeable nonselective cation channel (NSCC) in A7r5 cells: its lower concentrations (1 nM; lower [ET‐1]) activate only an SK&F 96365‐resistant channel (NSCC‐1), whereas its hig...
Gespeichert in:
Veröffentlicht in: | British journal of pharmacology 1999-03, Vol.126 (5), p.1107-1114 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | We have shown that in addition to voltage‐operated Ca2+ channel (VOC), endothelin‐1 (ET‐1) activates two types of Ca2+‐permeable nonselective cation channel (NSCC) in A7r5 cells: its lower concentrations (1 nM; lower [ET‐1]) activate only an SK&F 96365‐resistant channel (NSCC‐1), whereas its higher concentrations (10 nM; higher [ET‐1]) activate an SK&F 96365‐sensitive channel (NSCC‐2) as well.
We now characterized the effects of a blocker ofCa2+ entry channel LOE 908 on NSCCs and store‐operatedCa2+ channel (SOCC) in A7r5 cells, and using twodrugs, clarified the involvement of these channels in the ET‐1‐inducedincrease in the intracellular free Ca2+ concentrations([Ca2+]i). Whole‐cell recordingsand [Ca2+]i monitoring withfluo‐3 were used.
LOE 908 up to 10 μM had no effect on increases in [Ca2+]i induced by thapsigargin or ionomycin, but SK&F 96365 abolished them.
In the cells clamped at −60 mV, both lower and higher [ET‐1] induced inward currents with linear iv relationships and the reversal potentials of −15.0 mV. Thapsigargin induced no currents.
In the presence of nifedipine, lower [ET‐1] induced a sustained increase in [Ca2+]i, whereas higher [ET‐1] induced a transient peak and a sustained increase. The sustained increases by lower and higher [ET‐1] were abolished by removal of extracellular Ca2+, and they were suppressed by LOE 908 to 0 and 35%, respectively, with the LOE 908‐resistant part being abolished by SK&F 96365.
These results show that LOE 908 is a blocker of NSCCs without effect on SOCC, and that the increase in [Ca2+]i at lower [ET‐1] results from Ca2+ entry through NSCC‐1 in addition to VOC, whereas the increase at higher [ET‐1] involves NSCC‐1, NSCC‐2 and SOCC in addition to VOC.
British Journal of Pharmacology (1999) 126, 1107–1114; doi:10.1038/sj.bjp.0702416 |
---|---|
ISSN: | 0007-1188 1476-5381 |
DOI: | 10.1038/sj.bjp.0702416 |